The time to recommend antenatal HIV screening for all pregnant women has arrived

Medical Journal of Australia

Volumn 181, Issue 3, 2004, Pages 124-125

  Ziegler, John B ^a   Graves, Nicholas ^b  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANTIBODY DETECTION; ARTIFICIAL MILK; AUSTRALIA; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; DRUG COST; EDITORIAL; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; PATIENT COUNSELING; PRACTICE GUIDELINE; PREGNANCY; PRENATAL CARE; PRENATAL SCREENING; WORLD HEALTH ORGANIZATION;

EID: 4344625754     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb06199.x     Document Type: Editorial

References (16)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global summary of the HIV/AIDS epidemic, December 2003. Available at: www.unaids.org/html/pub/Topics/Epidemiology/Slides02/ Epicore2003_en_ppt.ppt (accessed Jun 2004).
2. Fassin D, Schneider H. The politics of AIDS in South Africa: beyond the controversies. BMJ 2003; 326: 495-497.
3. HIV-infected pregnant women and vertical transmission in Europe since 1986. European collaborative study. AIDS 2001; 15: 761-770.
4. Dorenbaum A, Cunningham CK, Gelber RD, et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA 2002; 288: 189-198.
5. National Centre in HIV Epidemiology and Clinical Research. 1999 HIV/AIDS, hepatitis C, and sexually transmissible infections in Australia. Annual surveillance report. Sydney: NCHECR, 1999. Available at: www.med.unsw.edu.au/nchecr/Downloads/99ansurvrpt.pdf (accessed Jun 2004).
6. McDonald AM, Li Y, Cruickshank MA, et al. Use of interventions for reducing mother-to-child transmission of HIV in Australia. Med J Aust 2001; 174: 449-452.
7. Australian National Council on AIDS and Related Diseases, Intergovernmental Committee on AIDS and Related Diseases. HIV testing policy. Canberra: Commonwealth Department of Health and Aged Care, 1998.
8. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS and related diseases in Australia. Annual surveillance report 1998. Sydney: NCHECR, 1998. Available at: www.med.unsw.edu.au/nchecr/Downloads/98ansurvrpt.pdf (accessed Jun 2004).
9. Garland SM, Duke JE, Woodhouse DR. Antenatal screening for HIV in Australia: time to revise policies? [letter]. Med J Aust 2000; 172: 188-189.
10. Elford J, MacDonald MA, Gabb RG, et al. Antenatal HIV antibody testing in Australia. Med J Aust 1995; 163: 183-185.
11. Spencer JD, Tibbits D, Tippet C, et al. Review of antenatal testing policies and practice for HIV and hepatitis C infection. Aust N Z J Public Health 2003; 27: 614-619.
12. Giles ML, Sasadeusz JJ, Garland SM, et al. An audit of obstetricians' management of women potentially infected with blood-borne viruses. Med J Aust 2004; 180: 328-332.
13. Graves N, Walker DG, McDonald AM, et al. Would universal antenatal screening for HIV infection be cost-effective in a setting of very low prevalence? Modelling the data for Australia. J Infect Dis 2004; 190: 166-174.
14. Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ 1997; 16: 1-31.
15. George B, Harris AH, Mitchell AS. Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in Australia. Pharmacoeconomics 2001; 19: 1-8.
16. Larriera A. Proposal for secret AIDS tests attacked. Sydney Morning Herald 1995; 1 April, 3.